Biocon Biologics signs pact with Eris Lifesciences for divesture of dermatology and nephrology…
Total transaction value of the divestment is Rs 3,660 million, inclusive of working capital conveyed as part of the deal
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
dermatology
Eris Lifesciences acquires nine dermatology brands from Dr Reddy’s for Rs 2,750 mn
Eris entered the dermatology segment through the acquisition of Oaknet Healthcare for Rs 6,500 million in May 2022 and…
Eli Lilly launches Copellor in India to treat moderate-to-severe plaque psoriasis
A humanised IgG4 monoclonal antibody, Copellor (Ixekizumab) is designed to specifically target IL-17A, a protein that plays a role…
Dermatology space to benefit most from five potential blockbusters
According to GBI Research, Dupixent is expected to face very little competition and as a result will generate the second highest…
DRL enters branded consumer health arena through acquisition of six OTC brands
DRL will build upon the sales and marketing efforts for these brands and continue to focus on their expansion into existing and…
Alembic Pharma in JV agreement with Orbicular
To develop and commercialise dermatology products for global markets